Atradius - Managing risk, enabling trade

Atradius worldwide

Local Atradius websites

Europe

Austria
Belgium
Bulgaria
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Luxembourg
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Spain
Sweden
Switzerland
Turkey
United Kingdom

Asia

China
Hong Kong SAR
India
Japan
Singapore

North America

Canada
Mexico
USA

South America

Brazil

Oceania

Australia
New Zealand

See all Atradius offices

Main menu

Home
About us
Products
Publications
News & Press
Careers
Contact

Publicaties

Veelbelovende opkomende markten voor 2018

Economic Note

Colombia,
Costa Rica,
Czech Republic,
India,
Indonesia,
Morocco,
Panama,
Vietnam

Agriculture,
Automotive/Transport,
Chemicals/Pharma,
Construction,
Consumer Durables,
Electronics/ICT,
Food,
General economic,
Machines/Engineering

11th January 2018

Het economisch herstel van opkomende markten zal in 2018 naar verwachting verder aan kracht winnen.

Handelsinformatie

Informatie over handelskansen waaronder de Atradius- wereldrisicokaart.

Vooruitzichten prestaties sectoren

Bekijk een snapshot van het kredietrisico en de bedrijfsprestaties van 14 grote sectoren in meer dan 30 landen. De vooruitzichten zijn gebaseerd op de beoordeling door de kredietanalisten van Atradius

Filter

by country

Filter by country

Filter by European countries Austria Belgium Bulgaria Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Lithuania Luxembourg Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom

Filter by European countries Bangladesh China Hong Kong SAR India Indonesia Japan Malaysia Philippines Singapore South Korea Taiwan Thailand Vietnam

Filter by European countries Canada Mexico USA

Filter by European countries Argentina Brazil Chile Colombia Costa Rica Panama Peru

Filter by European countries Bahrain Iran Jordan Kuwait Oman Qatar Saudi Arabia United Arab Emirates

Filter by European countries Australia New Zealand

Filter by European countries Algeria Angola Egypt Jordan Kenya Morocco South Africa Tanzania Tunisia

by sector

Filter by sector

Choose a sector Agriculture Automotive/Transport Chemicals/Pharma Construction Consumer Durables Electronics/ICT Financial Services Food General economic Machines/Engineering Metals Paper Services Steel Textiles

by keyword

Filter by keyword

Type a keyword to filter by

Schrijf u in

Schrijf u in voor meldingen over onze publicaties. Gebruik ons zoekfilter om uw keuzes te maken (land, sector of trefwoord) en ontvang wekelijks een e-mail wanneer er een nieuw rapport is verschenen.

Email address e.g. email@address.com

Showing 211-220 of 1407 items

View

10{staticMap.ItemsOnPage}
20{staticMap.ItemsOnPage}
50{staticMap.ItemsOnPage}

Pharmaceuticals Industry Trends China - 2022

Market Monitor

China

Chemicals/Pharma

15th March 2022

A vast market with growing sales opportunities

Pharmaceuticals Industry Trends Germany - 2022

Market Monitor

Germany

Chemicals/Pharma

15th March 2022

Robust output growth expected in 2022

Pharmaceuticals Industry Trends United Kingdom - 2022

Market Monitor

United Kingdom

Chemicals/Pharma

15th March 2022

Large backlog of medical treatments to sustain growth in the coming years

Pharmaceuticals Industry Trends France - 2022

Market Monitor

France

Chemicals/Pharma

15th March 2022

Healthy profit margins despite public pressure to lower sales prices

Pharmaceuticals Industry Trends Japan - 2022

Market Monitor

Japan

Chemicals/Pharma

15th March 2022

Growing share of generics could affect local producers

Pharmaceuticals Industry Trends India - 2022

Market Monitor

India

Chemicals/Pharma

15th March 2022

Increase in production of primary products planned to lower reliance on China

Pharmaceuticals Industry Trends Italy - 2022

Market Monitor

Italy

Chemicals/Pharma

15th March 2022

High days sales outstanding in the wholesalers segment

Pharmaceuticals Industry Trends Ireland - 2022

Market Monitor

Ireland

Chemicals/Pharma

15th March 2022

A major drug production hub with good growth prospects

Pharmaceuticals Industry Trends Switzerland - 2022

Market Monitor

Switzerland

Chemicals/Pharma

15th March 2022

Business margins expected to increase again in 2022

Pharmaceuticals Industry Trends Brazil - 2022

Market Monitor

Brazil

Chemicals/Pharma

15th March 2022

Stable profit margins despite inflationary pressures

Products

Credit Insurance
Multinationals
Credit Specialties
Debt Collections
Surety
Reinsurance
Case studies

News and Publications

Sustainability
Publications
News & Press
Country Risk Map
Industry Performance Forecast
Subscribe
Careers

Legal and Privacy

GDPR
Privacy Statement
Cookie Information
Speak Up channels
Phishing & Security
Legal Notice
Supplier Information
Disclaimer

A company of

Disclaimer

Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommen¬dation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.